Department of Biomedical and Clinical Sciences (BKV), Linköping University, Linköping, Sweden.
Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Trends Biotechnol. 2022 Oct;40(10):1195-1212. doi: 10.1016/j.tibtech.2022.03.011. Epub 2022 Apr 19.
Despite the great success of vaccines over two centuries, the conventional strategy is based on attenuated/altered microorganisms. However, this is not effective for all microbes and often fails to elicit a protective immune response, and sometimes poses unexpected safety risks. The expanding nano toolbox may overcome some of the roadblocks in vaccine development given the plethora of unique nanoparticle (NP)-based platforms that can successfully induce specific immune responses leading to exciting and novel solutions. Nanovaccines necessitate a thorough understanding of the immunostimulatory effect of these nanotools. We present a comprehensive description of strategies in which nanotools have been used to elicit an immune response and provide a perspective on how nanotechnology can lead to future personalized nanovaccines.
尽管疫苗在两个多世纪以来取得了巨大的成功,但传统的策略还是基于减毒/改变的微生物。然而,这种方法并不适用于所有的微生物,而且往往无法引发有效的保护性免疫反应,有时还会带来意想不到的安全风险。鉴于有大量的基于独特纳米颗粒 (NP) 的平台可以成功诱导特定的免疫反应,从而带来令人兴奋和新颖的解决方案,不断扩展的纳米工具包可能会克服疫苗开发中的一些障碍。纳米疫苗需要深入了解这些纳米工具的免疫刺激作用。我们全面介绍了使用纳米工具来引发免疫反应的策略,并就纳米技术如何引领未来的个性化纳米疫苗提供了一些看法。